You just read:

Aqualung Therapeutics Corporation Receives A $1.7 Million National Institute Of Health (NIH) Fastrack Award To Develop An Novel Immune-Based Therapeutic Antibody For Critically Ill Patients With Acute Lung Injury

News provided by

Aqualung Therapeutics Corporation

Jun 05, 2019, 07:53 ET